Aug 20, 2026 · 7 min
European shares split as retail falters and biotech gains
JD Sports Drops, Novonesis Gains, Sartorius Rises
The episode shows how weaker consumer demand and stronger forecasts are pulling European stocks in sharply different directions.
- 1JD Sports cuts its outlook as weaker sneaker sales reflect reduced discretionary spending.
- 2Novonesis gains after beating sales expectations and upgrading its guidance.
- 3Sartorius rises after UBS upgrades the German laboratory equipment maker.
Don't miss
JD Sports cuts its outlook as weaker sneaker sales expose the consumer-spending pressure weighing on the stock.
The brief
Stephen Carroll and James Woolcock introduce the report with Bloomberg’s Chloe Melley, who examines the European companies driving the day’s market moves.
JD Sports cuts its outlook as weaker sneaker sales point to pressure on discretionary spending, making the retailer the clearest casualty in the episode’s market snapshot.
Novonesis moves higher after a sales beat and upgraded guidance, showing how stronger financial expectations can quickly reset investor sentiment.
Sartorius also rises after UBS upgrades the German lab equipment maker, completing a contrast between consumer weakness and optimism around healthcare-related businesses.
What was said on this episode
3 statements · 2 positive · 1 negative
JD Sports has no imminent recovery promise
“there's really no promise of a recovery anytime soon for that company”
Listen at 2:09
Novonesis has multiple growth drivers across diversified markets
“it has a lot of different growth drivers”
Listen at 3:09
Analysts and investors view Novonesis’s latest update positively
“analysts and investors seem to be very positive on this latest update”
Listen at 3:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Mentioned
JD Sports
Novo Nordisk
UBSListen to the full episode and explore every guest, topic, and moment on PodLume.